How Psychedelics Are Revolutionizing Depression Treatment

New and innovative therapeutics to treat anxiety and depression are on the horizon with development of psychedelic molecules. Anthony Lacavera sits down with Dr. Michael P. Bogenschutz, Director of NYU Langone Center for Psychedelic Medicine, and Dr. Alex Belser, Chief Clinical Officer at Cybin, to discuss observations from clinical trials, excitement about the efficacy of treatment, and the specific design that maximizes benefit and interaction between the medication and supportive context.